Annual Accounts Payable
$5.82 M
-$8.86 M-60.37%
December 31, 2023
Summary
- As of February 7, 2025, PRAX annual accounts payable is $5.82 million, with the most recent change of -$8.86 million (-60.37%) on December 31, 2023.
- During the last 3 years, PRAX annual accounts payable has risen by +$1.73 million (+42.25%).
- PRAX annual accounts payable is now -60.37% below its all-time high of $14.67 million, reached on December 31, 2022.
Performance
PRAX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$15.01 M
+$6.82 M+83.16%
September 30, 2024
Summary
- As of February 7, 2025, PRAX quarterly accounts payable is $15.01 million, with the most recent change of +$6.82 million (+83.16%) on September 30, 2024.
- Over the past year, PRAX quarterly accounts payable has increased by +$5.61 million (+59.61%).
- PRAX quarterly accounts payable is now -11.63% below its all-time high of $16.99 million, reached on March 31, 2023.
Performance
PRAX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PRAX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.4% | +59.6% |
| 3 y3 years | +42.3% | -11.6% |
| 5 y5 years | +71.5% | -11.6% |
PRAX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.4% | at low | -11.6% | +158.1% |
| 5 y | 5-year | -60.4% | +118.0% | -11.6% | +462.8% |
| alltime | all time | -60.4% | +118.0% | -11.6% | +462.8% |
Praxis Precision Medicines Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.01 M(+83.2%) |
| Jun 2024 | - | $8.20 M(-12.9%) |
| Mar 2024 | - | $9.40 M(+61.7%) |
| Dec 2023 | $5.82 M(-60.4%) | $5.82 M(-18.9%) |
| Sep 2023 | - | $7.17 M(-10.5%) |
| Jun 2023 | - | $8.01 M(-52.8%) |
| Mar 2023 | - | $16.99 M(+15.8%) |
| Dec 2022 | $14.67 M | $14.67 M(+45.0%) |
| Sep 2022 | - | $10.12 M(-14.4%) |
| Jun 2022 | - | $11.82 M(-10.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $13.27 M(+23.1%) |
| Dec 2021 | $10.78 M(+163.7%) | $10.78 M(+42.9%) |
| Sep 2021 | - | $7.54 M(+1.9%) |
| Jun 2021 | - | $7.40 M(+28.2%) |
| Mar 2021 | - | $5.77 M(+41.2%) |
| Dec 2020 | $4.09 M(+53.3%) | $4.09 M(+18.4%) |
| Sep 2020 | - | $3.45 M(-6.4%) |
| Jun 2020 | - | $3.69 M(+38.3%) |
| Dec 2019 | $2.67 M(-21.4%) | $2.67 M |
| Dec 2018 | $3.39 M | - |
FAQ
- What is Praxis Precision Medicines annual accounts payable?
- What is the all time high annual accounts payable for Praxis Precision Medicines?
- What is Praxis Precision Medicines annual accounts payable year-on-year change?
- What is Praxis Precision Medicines quarterly accounts payable?
- What is the all time high quarterly accounts payable for Praxis Precision Medicines?
- What is Praxis Precision Medicines quarterly accounts payable year-on-year change?
What is Praxis Precision Medicines annual accounts payable?
The current annual accounts payable of PRAX is $5.82 M
What is the all time high annual accounts payable for Praxis Precision Medicines?
Praxis Precision Medicines all-time high annual accounts payable is $14.67 M
What is Praxis Precision Medicines annual accounts payable year-on-year change?
Over the past year, PRAX annual accounts payable has changed by -$8.86 M (-60.37%)
What is Praxis Precision Medicines quarterly accounts payable?
The current quarterly accounts payable of PRAX is $15.01 M
What is the all time high quarterly accounts payable for Praxis Precision Medicines?
Praxis Precision Medicines all-time high quarterly accounts payable is $16.99 M
What is Praxis Precision Medicines quarterly accounts payable year-on-year change?
Over the past year, PRAX quarterly accounts payable has changed by +$5.61 M (+59.61%)